NCT04881019View on ClinicalTrials.gov

PRediction Of Glycemic RESponse Study

Active, not recruitingOBSERVATIONAL
Enrollment

1,070

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

December 31, 2025

Conditions
Glycemic Response
Interventions
DEVICE

Continuous glucose monitoring

Continuous monitoring of blood sugar over a 10-day period.

Trial Locations (1)

92037

Scripps Research Translational Institute, San Diego

All Listed Sponsors
collaborator

CareEvolution Healthcare Technology

UNKNOWN

collaborator

Tempus AI

INDUSTRY

lead

Scripps Translational Science Institute

OTHER